Research Article
The Abnormal Expression of MicroRNA-542-3p in Hepatocellular Carcinoma and Its Clinical Significance
Table 2
Association of miRNA-542-3p expression with clinicopathological parameters in HCC (TCGA).
| Clinical parameters | n | miRNA-542-3p relative expression (2−ΔΔCt) | Mean ± SD | t | P |
| Age | <50 | 8 | 0.719 ± 0.407 | 1.273 | 0.222 | ≥ 50 | 45 | 1.133 ± 0.926 | Gender | Male | 30 | 0.883 ± 0.472 | −1.6408 | 0.113 | Female | 23 | 1.314 ± 1.190 | AFP (ng/mL) | <400 | 30 | 1.080 ± 0.843 | −0.496 | 0.623 | ≥ 400 | 7 | 0.917 ± 0.379 | Missing data | 16 | | Cirrhosis | Negative | 25 | 0.950 ± 0.529 | 0.782 | 0.439 | Positive | 13 | 1.088 ± 0.500 | Missing data | 15 | | TNM stage | I-II | 29 | 0.872 ± 0.487 | 1.469 | 0.149 | III-IV | 15 | 1.228 ± 1.1253 | Missing data | 9 | | HBV | Negative | 31 | 1.101 ± 1.057 | −0.303 | 0.763 | Positive | 22 | 1.027 ± 0.553 | Portal invasion | Negative | 32 | 1.295 ± 1.039 | −2.059 | 0.045 | Positive | 15 | 0.721 ± 0.390 | Missing data | 6 | |
|
|
Data are presented as mean ± SD. . |